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ABSTRACT: In this work, the adsorption behavior of a tricyclic antidepressant, amitriptyline
hydrochloride, onto several activated carbons (ACs) is reported. The adsorption was done using
in vitro simulated gastric and intestinal fluid at 37◦C to test the performance of the carbons
as treatment in overdose cases. The tested materials were one commercial AC (carbomix) and
two ACs produced in our laboratory. The highest adsorption capacity was achieved by car-
bomix, followed by the laboratory-made carbons that still have a very good performance with
adsorption capacity up to 120 and 100mg/g for the gastric and intestinal fluids, respectively.
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INTRODUCTION
Many legal and illegal drugs are frequently taken in
excess, which can constitute a relevant health prob-
lem. For the majority of these drugs, the treatment
of overdose cases at hospital is done by oral adminis-
tration of activated carbon (AC) slurry, as there is no
specific antidote. Amitriptyline (AMT) is a tricyclic
antidepressant (TCA) drug used for the treatment
of several mental conditions that is commonly in-
volved in overdose cases leading to severe toxic effects,
namely in the cardiovascular system and in the pe-
ripheral and central nervous systems.1 These drugs
are among the commonest causes of fatal and non-
fatal drug poisoning in the world. Symptoms of an
overdose usually develop within an hour of ingestion
and may start with rapid heartbeat, dilated pupils,
flushed face, and agitation, which can progress to
confusion, loss of consciousness, seizures, irregular
heart rate, hypotension, and pulmonary edema and
ending in respiratory arrest, convulsions, ventricular
arrhythmias, coma, and death. The toxic effects are
especially acute when young children take the drug,
in this case one or two pills can cause acute toxicity.2,3
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TCAs are one of the oldest classes of antidepressants
but still extensively used worldwide because of its
lower price when compared with other more recently
developed drugs, namely the selective serotonin re-
uptake inhibitors (SSRIs). TCAs are comparatively
more toxic, in particular at low dosages, with larger
side effects than SSRIs.
Several in vivo and in vitro studies have proven the
efficacy of AC to adsorb numerous drugs and decrease
their toxic impact.4–8 The AC provides the elimina-
tion of absorbed toxins interrupting the hepatic circu-
lation and promoting the passive diffusion from the
capillaries of themucous intestinal toward the lumen.
It is not demonstrated if the gastric wash combined
with activated coal is better than the latter only.9
The objective of the work here reported is to study
the adsorption of AMT onto ACs in order to study the
efficiency of using these materials to treat overdose
cases.
EXPERIMENTAL
Pharmaceutical Product
Amitriptyline hydrochloride (reference standard,
pKa 9.42) used in this study was supplied by Sigma–
Aldrich (St. Louis, Missouri). The chemical structure
is shown in Figure 1 and consists of a central ring
that adopts a bent conformation.
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Figure 1. Molecular structure of amitriptyline HCl.
Activated Carbons
Three ACs were used. One sample is commercially
available for use in medicinal applications: Carbomix
(Norit N.V., the Netherlands), designated carb. Two
AC samples were produced in our laboratory using
cork (COR849) and eucalyptus pulp (P834) as precur-
sors. The ACs were produced using a horizontal tubu-
lar furnace and carbon dioxide as activating agent.
Experimental details can be found in Ref.10.
Materials Characterization
The porosity was evaluated by the analysis of
the nitrogen adsorption isotherms at 77K using
suitable methods, namely Brunauer-Emmett-Teller
(BET) that provides the BET surface area ABET;
and the ∝s method that provides the total pore
volume, VS, and the external area, Aext. Nitro-
gen adsorption isotherms at 77 K were recorded
in a Quadrasorb-Tri, Quantachrome Instruments
(Boynton Beach, Florida). The point of zero charge
(pzc) was determined by mass titrations using 7 wt %
suspensions of the ACs inNaNO3 0.1M solutionswith
initial pH adjusted to 3, 6, and 10. The suspensions
were placed in a thermostat bath at 25◦C and stirred
for 48 h, then filtered and the pH measured, details
given elsewhere.11 The pzc value is given by themedia
of the measured pHs.
AMT Adsorption Study
The adsorption study of AMT was performed in simu-
lated gastric and intestinal conditions at 37◦C. A stock
solution of AMT (1 g/L) was prepared in simulated
gastric fluid pepsin omitted, pH 1.2, which consists of
2.0 g/L NaCl and 7 mL/L of concentrated HCl. Other
stock solution of 1 g/L was prepared in simulated in-
testinal fluid pepsin omitted, pH 7.5, which consists
of 50 mL NaH2PO4 0.1 M and 42.5mL NaOH 0.1M
for 1 L of solution.
Batch adsorption experiments were carried out in
a series of Erlenmeyer flasks of 100mL capacity cov-
ered with Teflon and inserted in a shaking thermostat
bath at 37◦C for 72 h using 0.01 g of adsorbent and
25 mL of AMT solutions with variable concentrations
up to 255mg/L.
The determination of AMT concentration was done
by ultraviolet absorption at 240nm using a Nicolet
evolution 300 ultraviolet–visible spectrophotometer.
The absorbance of the solutions was made in tripli-
cate. The calibration curve obeys the Beer law in all
the concentration range tested, 2–255mg/L, with very
good linearity (r2 = 0.996).
RESULTS AND DISCUSSION
Materials Characterization
The results of the materials characterization in terms
of porosity and maximum adsorption capacity are re-
ported in Table 1. It can be seen that the AC samples
tested are all basic, with pzc always higher than 8.
The sample with the highest surface area and pore
volume is carbomix with 1396m2/g and 0.70 cm3/g,
respectively. The laboratory-made carbons have less
developed porous structure; however, the mesopore
volume of sample COR849 is bigger than the val-
ues observed for the other carbons. The percentage
of pores in the mesopores range (mean pore width
between 2 and 50nm) varies with the sample prove-
nience assuming the value of 21%, 31%, and 62% for
P834, carbomix, and COR849, respectively.
AMT Adsorption Study
The AMT adsorption study was performed at normal
body temperature and in both simulated gastric and
intestinal fluids because these are the organs where
the drug is absorbed by the human organism when it
is ingested. At both pH conditions employed, AMT is
mainly found in its protonated form. Figure 2 shows
Table 1. Characterization of the Activated Carbons and Maximum Adsorption Capacity
Porosity
BET αs Maximum Adsorption Capacity (mg/g)
Sample ABET (m2/g) Vs (cm3/g) Aext (m2/g) Vmesa (cm3/g) pzc pH 1.2 pH 7.5
P834 772 0.38 21 0.08 10.26 120 70
COR849 839 0.50 97 0.31 8.65 120 100
Carbomix 1396 0.70 71 0.22 8.01 300 500
aThe volume of mesopores was taken from the isotherms by subtracting the adsorbed volume at relative pressure of 0.1 (micropore volume) to the total
pore volume.
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Figure 2. Amitriptyline adsorption isotherms at 37◦C.
the milligrams of AMT adsorbed per gram of car-
bon (Nads) versus the equilibrium concentrations in
simulated fluids at 37◦C (Ceq). From the adsorption
isotherms, we can obtain the maximum adsorption
capacity that is shown in Table 1.
The maximum adsorption capacity is observed for
carbomix that can be due to both its higher pore vol-
ume and BET surface area. Also, sample COR849
shows slightly higher adsorption capacity than P834
for the same reasons.
Different carbon types, commercial and laboratory
made, have also dissimilar behavior for adsorption at
pH 1.2 and 7.5. By one side, carbomix shows higher
adsorption capacity at pH 7.5, which is consistent
with previous report data on the adsorption of flu-
oxetine onto the same carbon.12 This indicates that
the adsorption mechanism is determined by the elec-
trostatic interactions between the AMT molecule and
the ionized surface of the carbon. At working pH,
AMT is protonated acquiring a positive charge that
is proportional to the pH decrease. The surface of the
ACs achieves a net charge that depends on the ion-
ization of the functional groups determined by the
solution pH; when the pH is inferior or superior than
the pzc value, the surface became positive or nega-
tive. The charge intensity is proportional to the dif-
ference between the solution pH and the pzc value.
Therefore, at pH 1.2, the electrostatic interactions
are more repulsive, leading to lower adsorption ca-
pacities. On the contrary, the adsorption mechanism
of the laboratory-made carbons is not significantly in-
fluenced by the electrostatic interaction as indicated
by the fact of showing higher adsorption capacity at
pH 1.2. In these cases, it can be hypothesized that
the adsorption mechanism is mainly determined by
dispersive interactions, or specific chemical interac-
tions, between the delocalized electrons of the carbon
basal planes, or the surface functional groups, and the
AMTmolecular structure that are somehow increased
at pH 1.2.
COR849 and P834 samples can be used to prevent
the absorption of the drug by the human body in the
event of a dug overdose. Usually, the normal dose
of AC slurry to treat overdoses involves the use of
about 60 g of AC. If we consider the maximum ad-
sorption capacity of each sample, it would mean that
the laboratory carbons could adsorb 4–7 g of the drug.
This performance is sufficient to treat a person that
had ingested a full box of 30 pills of 100mg dosage
of AMT. Therefore, we can state that, despite their
lower adsorption capacity, the laboratory-made car-
bons can constitute an interesting alterative to the
commercial product due to their different biochemi-
cal structure that is originated by the use of natural
biomass as precursor for the ACs production. Also,
the use of agricultural and industrial wastes to pro-
duce ACs should be underlined, as it constitutes an
environmental friendly process.
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